Literature DB >> 21528849

Graphene for controlled and accelerated osteogenic differentiation of human mesenchymal stem cells.

Tapas R Nayak1, Henrik Andersen, Venkata S Makam, Clement Khaw, Sukang Bae, Xiangfan Xu, Pui-Lai R Ee, Jong-Hyun Ahn, Byung Hee Hong, Giorgia Pastorin, Barbaros Özyilmaz.   

Abstract

Current tissue engineering approaches combine different scaffold materials with living cells to provide biological substitutes that can repair and eventually improve tissue functions. Both natural and synthetic materials have been fabricated for transplantation of stem cells and their specific differentiation into muscles, bones, and cartilages. One of the key objectives for bone regeneration therapy to be successful is to direct stem cells' proliferation and to accelerate their differentiation in a controlled manner through the use of growth factors and osteogenic inducers. Here we show that graphene provides a promising biocompatible scaffold that does not hamper the proliferation of human mesenchymal stem cells (hMSCs) and accelerates their specific differentiation into bone cells. The differentiation rate is comparable to the one achieved with common growth factors, demonstrating graphene's potential for stem cell research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21528849     DOI: 10.1021/nn200500h

Source DB:  PubMed          Journal:  ACS Nano        ISSN: 1936-0851            Impact factor:   15.881


  140 in total

1.  Cellular behaviours of bone marrow-derived mesenchymal stem cells towards pristine graphene oxide nanosheets.

Authors:  Changbo Wei; Zifeng Liu; Fangfang Jiang; Binghui Zeng; Mingdi Huang; Dongsheng Yu
Journal:  Cell Prolif       Date:  2017-08-03       Impact factor: 6.831

Review 2.  Biological interactions of graphene-family nanomaterials: an interdisciplinary review.

Authors:  Vanesa C Sanchez; Ashish Jachak; Robert H Hurt; Agnes B Kane
Journal:  Chem Res Toxicol       Date:  2011-10-21       Impact factor: 3.739

3.  Cell-laden microengineered and mechanically tunable hybrid hydrogels of gelatin and graphene oxide.

Authors:  Su Ryon Shin; Behnaz Aghaei-Ghareh-Bolagh; Tram T Dang; Seda Nur Topkaya; Xiguang Gao; Seung Yun Yang; Sung Mi Jung; Jong Hyun Oh; Mehmet R Dokmeci; Xiaowu Shirley Tang; Ali Khademhosseini
Journal:  Adv Mater       Date:  2013-09-01       Impact factor: 30.849

4.  The effect of graphene substrate on osteoblast cell adhesion and proliferation.

Authors:  Ashkan Aryaei; Ahalapitiya H Jayatissa; Ambalangodage C Jayasuriya
Journal:  J Biomed Mater Res A       Date:  2013-11-01       Impact factor: 4.396

5.  Antioxidant activity of omega-3 derivatives and their delivery via nanocages and nanocones: DFT and experimental in vivo investigation.

Authors:  Houshang Najafi; Saeed Changizi-Ashtiyani; Meysam Najafi
Journal:  J Mol Model       Date:  2017-10-28       Impact factor: 1.810

6.  Preparation and functionalization of graphene nanocomposites for biomedical applications.

Authors:  Kai Yang; Liangzhu Feng; Hao Hong; Weibo Cai; Zhuang Liu
Journal:  Nat Protoc       Date:  2013-11-07       Impact factor: 13.491

7.  Tissue engineering: new tools for old problems.

Authors:  Rogério P Pirraco; Rui L Reis
Journal:  Stem Cell Rev Rep       Date:  2015-06       Impact factor: 5.739

8.  Controlling differentiation of adipose-derived stem cells using combinatorial graphene hybrid-pattern arrays.

Authors:  Tae-Hyung Kim; Shreyas Shah; Letao Yang; Perry T Yin; Md Khaled Hossain; Brian Conley; Jeong-Woo Choi; Ki-Bum Lee
Journal:  ACS Nano       Date:  2015-04-08       Impact factor: 15.881

9.  In vivo compatibility of graphene oxide with differing oxidation states.

Authors:  Stefanie A Sydlik; Siddharth Jhunjhunwala; Matthew J Webber; Daniel G Anderson; Robert Langer
Journal:  ACS Nano       Date:  2015-04-10       Impact factor: 15.881

10.  Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.

Authors:  Raj Kumar Thapa; Yongjoo Choi; Jee-Heon Jeong; Yu Seok Youn; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Pharm Res       Date:  2016-08-29       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.